Hemodynamic Responses to Cardio-respiratory Events in Preterm Infants

Preterm Birth Clinical Trial

Official title:

Cardiovascular and Cerebrovascular Responses to Cardio-respiratory Events in Very Preterm Infants During the Transitional Period

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04184245
• Other study ID #: SO-CRE-2
• Status: Completed
• Start date: February 22, 2018
• Est. completion date: January 3, 2020

Study information

• Verified date: January 2020
• Source: Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Intermittent episodes of hypoxemia and/or bradycardia, also defined as cardio-respiratory events (CRE) are very frequent in preterm infants and may result in transient hypoxia and hypoperfusion of target organs, with possible clinical implications. The hemodynamic instability that characterizes the first 72 hours of life, also called as transitional period, place preterm infants at high risk of complications and may contribute to enhance fluctuations in end-organ perfusion and oxygenation induced by CRE. In this study we aimed to explore cardiovascular and cerebrovascular changes determined by different CRE types in preterm infants during the transitional period.

Description:

Intermittent episodes of hypoxemia and/or bradycardia, also defined as cardio-respiratory events (CRE) are very frequent in preterm infants and may result in transient hypoxia and hypoperfusion of target organs, with possible clinical implications. The hemodynamic instability that characterizes the first 72 hours of life, also called as transitional period, place preterm infants at high risk of complications and may contribute to enhance fluctuations in end-organ perfusion and oxygenation induced by CRE. Moreover, during this period, several clinical variables (e.g., antenatal steroid administration, gestational age [GA], patent ductus arteriosus [PDA], respiratory support etc.) may contribute to modulate the hemodynamic fluctuations in response to CRE.

Hence, this study aims:

• to explore changes in the main cardiovascular and cerebrovascular parameters elicited by different CRE types

• to evaluate whether different antenatal, perinatal and postnatal factors may influence the observed cardiovascular and cerebrovascular responses to CRE.

Infants born at S. Orsola-Malpighi Hospital are consecutively enrolled in this observational, prospective study if fulfilling the following eligibility criteria: gestational age (GA) <32 weeks' gestation, birth weight <1500 g, 0-12 hours of life, written informed consent obtained from the parents/legal guardians of each infant.

As routinely performed in infants with the eligible characteristics, the enrolled infants undergo a simultaneous, continuous and non-invasive monitoring of

• peripheral oxygen saturation (SpO2) and heart rate (HR) using a pulse oximeter

• cerebral tissue oxygenation index (cTOI) and cerebral total hemoglobin index (cTHI), which represents a proxy of cerebral blood flow, using near infrared spectroscopy. Cerebral fraction of oxygen extraction (cFTOE) is also calculated as follows: (SpO2-cTOI)/SpO2.

• cardiovascular parameters (cardiac output [CO], stroke volume [SV], cardiac contractility index [ICON], systemic vascular resistance [SVR]) using electrical cardiometry.

In the enrolled infants, each monitoring device is connected via a RS232 cable to a laptop running ICM+® (https://icmplus.neurosurg.cam.ac.uk/, Cambridge Enterprise, UK), a software tool that allows a real-time synchronized multi-parametric data collection, which recorded the above mentioned parameters continuously, from the time of enrollment up to 72 hours of life.

Cardiorespiratory event types are classified on the basis of SpO2 and HR values as follows:

• isolated desaturation (ID): SpO2 <85% and classified into mild (SpO2 80-84%), moderate (SpO2 70-79%) and severe (SpO2 <70%).

• isolated bradycardia (IB): any HR drop <100 bpm or >30% from baseline values, calculated daily over the first 72 hours of life

• desaturation and bradycardia occurring within a 60-sec time window: combined events (DB).

The following antenatal and neonatal data are tracked down on a specific case report form:

GA, antenatal steroids (complete course vs. incomplete course or not given) evidence of reversed end-diastolic flow at antenatal umbilical Doppler (uREDF) (present vs. absent); ventilatory status over the first 72 hours of life (continuous positive airway pressure [CPAP] vs. nasal cannulas or self-ventilating in air [SVIA]); surfactant administration; development of IVH over the first 72 hours of life.

A screening echocardiogram is routinely performed at the time of enrollment and repeated 6-12 hourly in the presence of a patent ductus arteriosus (PDA) or 12-24 hourly if there is no evidence of PDA. Based on echocardiographic features, the ductal status is classified as follows: no evidence of PDA (noPDA), restrictive PDA (rPDA; restrictive shunt pattern and left atrium to aortic root ratio [LA:Ao] ratio <1.5), hemodynamically significant PDA (hsPDA; pulsatile shunt pattern, LA:Ao ratio ≥1.5 or presence of reversed end-diastolic flow either in the descending aorta or in the anterior cerebral artery).

For statistical analysis, percentage changes of cardiovascular (CO, ICON, SVR) and cerebrovascular (cTOI, cTHI, cFTOE) parameters will be compared between different CRE types (ID, DB and IB) using Kruskal-Wallis test. Generalized estimating equation (GEE) models will be used to analyze the concomitant effect of clinical variables (e.g., GA, uREDF, antenatal steroids, ductal and ventilatory status etc.) on the percentage changes of the study parameters. IBM SPSS, version 25.0, will be used for statistical analysis. The significance level is set at p<0.05.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: January 3, 2020
• Est. primary completion date: December 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 3 Days

Eligibility

Inclusion Criteria:

• gestational age <32 weeks' gestation AND/OR birth weight <1500 g

Exclusion Criteria:

• major congenital malformations

• congenital heart disease

• mechanical ventilation

Related Conditions & MeSH terms

• Apnea of Prematurity
• Bradycardia
• Bradycardia Neonatal
• Cardiac Output, Low
• Ductus Arteriosus, Patent
• Hypoxia
• Hypoxia Neonatal
• Hypoxia, Brain
• Patent Ductus Arteriosus
• Premature Birth
• Preterm Birth

Locations

Country	Name	City	State
Italy	S. Orsola-Malpighi University Hospital	Bologna	Emilia-Romagna

Sponsors (1)

Lead Sponsor	Collaborator
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Increase/reduction of cTOI during isolated desaturation, isolated bradycardia and desaturation-bradycardia	Comparison of percentage cTOI changes (cTOI at baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia	0-72 hours of life
Primary	Increase/reduction of cFTOE during isolated desaturation, isolated bradycardia and desaturation-bradycardia	Comparison of percentage cFTOE changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia	0-72 hours of life
Primary	Increase/reduction of cTHI during isolated desaturation, isolated bradycardia and desaturation-bradycardia	Comparison of percentage cTHI changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia	0-72 hours of life
Primary	Increase/reduction of CO during isolated desaturation, isolated bradycardia and desaturation-bradycardia	Comparison of percentage CO changes (CO at baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia	0-72 hours of life72 hours
Primary	Increase/reduction of SV during isolated desaturation, isolated bradycardia and desaturation-bradycardia	Comparison of percentage SV changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia	0-72 hours of life
Primary	Increase/reduction of ICON during isolated desaturation, isolated bradycardia and desaturation-bradycardia	Comparison of percentage ICON changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia	0-72 hours of life
Primary	Increase/reduction of SVR during isolated desaturation, isolated bradycardia and desaturation-bradycardia	Comparison of percentage SVR changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia	0-72 hours of life
Secondary	Effect of neonatal characteristics on cerebrovascular parameters	Generalized estimating equation (GEE) analysis evaluating the effect of clinical variables (e.g., GA, uREDF, antenatal steroids, ductal and ventilatory status etc.) on percentage changes of cTOI, cFTOE, cTHI.	0-72 hours of life
Secondary	Effect of neonatal characteristics on cardiovascular parameters	Generalized estimating equation (GEE) analysis evaluating the effect of clinical variables (e.g., GA, uREDF, antenatal steroids, ductal and ventilatory status etc.) on percentage changes of CO, SV, ICON, SVR	0-72 hours of life